SLU-PP-332 | ERR Agonist
US$ 28.85
glp 1 parkinson's Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine Are GLP-1 diabetes drugs like
Description
Pregnancy represents another absolute barrier to GLP-1 therapy
It is not independently audited by this publication
To that end, internists and other (largely OB/GYN and cardiology) specialists are adding GLP-1s to their prescribing and growing quickly within the prescribing pool
The most frequent adverse events with survodutide versus placebo were nausea (66% versus 23%), diarrhea (49% versus 23%), and vomiting (41% versus 4%) 30
Long-term efficacy of liraglutide in Indian patients with type 2 diabetes in a real-world setting
